Diagnosis and Management of Diabetic Foot Infections
Andrew J.M. Boulton, David G. Armstrong, Matthew J. Hardman, Matthew Malone, John M. Embil, Christopher E. Attinger, Benjamin A. Lipsky, Javier Aragón‐Sánchez, Ho Kwong, Gregory S. Schultz, Robert S. Kirsner
Abstract
The first sections herein cover the impact of infection on healing of experimental wounds (p. 2), the importance of biofilms (p. 4), and a general overview of the microbiology of DFIs (p. 6). Although debridement of DFUs was covered in the first compendium, we deemed it important enough to include here as well, given its pivotal role in the management of DFIs. Subsequent sections cover the management of infected DFUs (p. 9) and discussions of antibiotics versus surgery for osteomyelitis (p. 12) and the OVIVA trial (p. 13). There is little doubt that the OVIVA trial will challenge the current management of osteomyelitis, in which IV antibiotics are still commonly used. The remaining sections cover potential topical treatments for DFIs (p. 15) and the role of modern technology in infection control (p. 17).